Ingersoll Rand Inc., a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Dave Barry Plastics, further expanding the company’s life sciences portfolio.
Ireland-based Dave Barry Plastics designs and manufactures plastic product solutions for life science and healthcare technology industries. These types of product solutions are used in clean rooms, which are specially designed to reduce the risk of contamination during the manufacturing, packaging, and storage process. Dave Barry Plastics will join the life sciences platform within the precision and science technologies (P&ST) segment.
“The acquisition of Dave Barry Plastics reflects our commitment to expanding our portfolio with innovative, high-performance solutions,” says Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “Their expertise in custom plastic products for the biopharmaceutical, pharmaceutical, and medical device industries will greatly enhance Ingersoll Rand’s life science capabilities. We are excited to welcome the Dave Barry Plastics team to Ingersoll Rand as we continue driving growth through purposeful, direct investments.”
The acquisition supports the company’s growth strategy with compelling opportunities for market expansion within life sciences